랩코프 (LH) 주가

랩코프(LH)는 NYSE에 상장된 Healthcare · Diagnostics & Research 기업입니다. 현재가 $321.11 (-0.50%), 시가총액 $20.95B, PER (주가수익비율) 22.63, 52주 최저~최고 $241.34 ~ $290.93.

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, PAP tests, hemoglobin A1C, PSA, tests for sexually transmitted diseases, vitamin D testing, microbiology cultures and procedures, and alcohol and other substance abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target specific diseases; services related to anatomic pathology/oncology, cardiovascular disease, coagulation, diagnostic genetics, endocrinology, infectious dis

핵심 지표

• 현재가: $321.11 (-0.50%)
• 시가총액: $20.95B
• PER (주가수익비율): 22.63
• 52주 최저~최고: $241.34 ~ $290.93
• 섹터: Healthcare
• 산업: Diagnostics & Research
• 거래소: NYSE

랩코프의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

랩코프 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 4.45

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 2.35
• 순이익률: 0.07%
• 영업이익률: 0.11%
• 배당수익률: 0.01%

자주 묻는 질문